Using qualified health claims and disclaimers correctly on supplement labels


Published on 05/12/2025

Using Qualified Health Claims and Disclaimers Correctly on Supplement Labels

The regulation of dietary supplements is a critical area for compliance professionals within the health and nutrition industry. This article serves as a comprehensive guide on utilizing qualified health claims and disclaimers on dietary supplement labels, focusing on the nuances between structure/function claims and disease claims. Understanding these distinctions is essential not only for regulatory compliance but also for maintaining consumer trust.

Understanding Dietary Supplement Labeling Regulations

The FDA sets the foundation for dietary supplement labeling through the Food, Drug, and Cosmetic Act. Within this framework, products must adhere to claims specific to their intended use, backed by appropriate substantiation. The primary classifications for claims on dietary supplements are structure/function

claims and claims related to diseases. Being able to distinguish between these is crucial for compliance.

Structure/function claims describe the role of a nutrient or dietary ingredient intended to affect the structure or function in humans. For example, a product may claim it “supports immune health.” In contrast, disease claims explicitly state that a product can prevent or treat a specific disease, such as “may reduce the risk of heart disease.” The latter types of claims are not permissible for dietary supplements unless validated through rigorous scientific evidence and pre-market FDA approval.

The key regulations governing dietary supplement claims arise from 21 CFR 101, which outlines labeling regulations, including the requirements for affixed disclaimers and substantiation. It is imperative that labeling adheres to these substantive regulations to minimize the risk of receiving FDA warning letters due to misleading or unsubstantiated claims.

Differentiating Between Structure/Function Claims and Disease Claims

When discussing claims on dietary supplements, it is vital to draw a clear distinction between structure/function claims and disease claims to ensure compliance with FDA claim rules.

See also  FDA Compliance for Dietary Supplements & Nutritional Products: Complete U.S. Regulatory Guide 2026

Structure/Function Claims

Structure/function claims can be made without prior FDA approval as long as the claims meet the regulatory criteria established by the FDA. To qualify for this exemption, the claims must:

  • Describe how a product affects the body’s structure or function.
  • Be truthful and not misleading.
  • Be substantiated by evidence that must exist at the time of the claim.

For example, a claim stating that a product “aids in muscle recovery” could be validated with adequate scientific support demonstrating how specific ingredients contribute to this function.

However, any affirmative statements regarding a product’s ability to prevent diseases may trigger the FDA’s scrutiny. Claims such as “reduces high blood pressure” would qualify as disease claims and require pre-market approval to substantiate their validity.

Disease Claims

As previously mentioned, disease claims are more stringent. Any product making a disease claim must adhere to a stricter regulatory pathway as defined in 21 CFR 101.93. Companies must either provide substantial scientific evidence or complete a formal application for a health claim related to a specific disease state.

All disease claims made on dietary supplements must be supported by evidence typically comprising of scientific studies published in peer-reviewed journals. Additionally, claims must undergo rigorous evaluation through an FDA application process if the product is intended to prevent or treat diseases. It is paramount to understand the distinction to avoid inadvertently making a disease claim when intending to emphasize a structure/function benefit.

Implementing Qualified Health Claims

Qualified health claims are ones that are not fully endorsed by the FDA but possess enough supporting evidence to justify limited use. These claims may be used but must be accompanied by a disclaimer and a description of the totality of evidence. The FDA Bulletin on qualified health claims provides specific guidelines on how to formulate these claims and the related disclaimers.

To be compliant when using qualified health claims, dietary supplement manufacturers must follow these steps:

  • Ensure proper substantiation: Evaluate all scientific evidence surrounding the proposed health claim. The evidence must be adequately substantiated to ensure consumer safety and protection.
  • Create clear disclaimers: Accompany the health claims with appropriate disclaimers that communicate potential limitations or controversies related to the evidence supporting the claim.
  • Adhere to proper terminology: Use language that accurately reflects the strength of the evidence; avoid deceptive language that might imply a stronger endorsement than is appropriate.
  • Consult the FDA Guidance Document: Reference the relevant FDA guidance documents to determine compliance with specific regulations regarding health claims.
See also  The rise of data integrity and electronic records themes in warning letters

Labeling Requirements and Marketing Review

The FDA emphasizes the importance of accurate and truthful labeling. In addition to making health claims, dietary supplement labels must also comply with general labeling regulations, which include:

  • Product identity and net quantity of contents
  • Name and place of business of the manufacturer, packer, or distributor
  • Directions for use
  • Supplement facts panel, including a list of dietary ingredients
  • Any pertinent disclaimers regarding claims made

Marketers should perform a robust review of labeling and advertising materials to ensure they meet compliance requirements. During this review, it is essential to cross-reference marketing materials with actual product formulations and labeling to avoid discrepancies. Regularly reviewing marketing practices will help reduce the risk of receiving warning letters due to issues surrounding misleading information or unsubstantiated claims. Companies should aim to operate with transparency and clarity to foster trust among consumers.

Common Missteps and Consequences

Regulatory compliance in dietary supplement labeling involves navigating various complexities. Making improper claims that blur the lines between structure/function and disease claims can lead to serious repercussions. Common missteps include:

  • Improperly labeling structure/function claims as disease claims.
  • Using anecdotal evidence rather than scientifically substantiated research.
  • Failing to include sufficient disclaimers with qualified health claims.
  • Inaccurately depicting the relationship between the product and health outcomes.

The consequences of these missteps can be severe, including:

  • Issuance of warning letters from the FDA.
  • Legal battle over false advertising claims.
  • Loss of public trust and significant brand reputational damage.

Thus, ensuring compliance with FDA regulations and adhering to best practices in health claims and disclaimers is critical for maintaining legitimacy in the market.

Best Practices and Conclusions

The pathway to ensuring compliance with FDA regulations on dietary supplement labeling can be complex. However, adhering to the below best practices can significantly mitigate compliance risks:

  • Stay Informed: Regularly review and stay updated on the latest FDA regulations, guidance documents including those specifically addressing health claims.
  • Engage Qualified Professionals: Consider hiring regulatory experts or consultants to assist in the review of labeling and marketing claims.
  • Conduct Routine Audits: Regular audits of labels and marketing materials can help ensure compliance before products reach the market.
  • Document Everything: Maintain thorough records of substantiation and claims made, providing materials necessary if challenged by the FDA.
See also  Global comparison of claim rules: US FDA vs EU EFSA for supplements

In conclusion, navigating the complex world of dietary supplement labeling involves understanding the differences between structure/function claims and disease claims, coupled with the implementation of qualified health claims and disclaimers. This not only helps ensure adherence to FDA regulations but also promotes ethical marketing practices. By investing in compliant labeling and understanding claim substantiation, businesses can protect themselves from regulatory scrutiny while providing safe and effective products to consumers.